Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546803 · ClinicalTrials.gov registry record
3M Cavilon Advanced Skin Protectant for the Prophylaxis of Radiation Dermatitis
A clinical trial of Radiation Dermatitis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT03546803: Completed study of Radiation Dermatitis, sponsored by Mayo Clinic.
NCT03546803 is a study of Radiation Dermatitis that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants, below the 48-participant average among 5 other Radiation Dermatitis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03546803, a study of Radiation Dermatitis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study observes a liquid skin protectant that is a polymeric-cyanoacrylate solution designed to protect intact or damaged skin due to radiation.
Primary Outcome
To compare radiation dermatitis severity in irradiated skin protected by a liquid skin protectant (3M™ Cavilon™ Advanced Skin Protectant) that rapidly dries versus uncovered skin (internal control) as determined by a panel.
Conditions Studied
Interventions
- OTHER 3M™ Cavilon™ Advanced Skin Protectant
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2019-08-12 |
What the finished NCT03546803 record still lists
NCT03546803 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 48-participant average among 5 other Radiation Dermatitis trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Radiation Dermatitis appearing as the primary indexed condition, and to 1 intervention - of which 3M™ Cavilon™ Advanced Skin Protectant is the first listed.
NCT03546803 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03546803 about?
NCT03546803 is a clinical study titled "3M Cavilon Advanced Skin Protectant for the Prophylaxis of Radiation Dermatitis". This study observes a liquid skin protectant that is a polymeric-cyanoacrylate solution designed to protect intact or damaged skin due to radiation.
What is the current status of trial NCT03546803?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2018-02-19. Estimated completion is 2019-08-12.
What conditions does trial NCT03546803 study?
This clinical trial studies the following conditions: Radiation Dermatitis.
What interventions are being tested in trial NCT03546803?
The interventions under investigation include: 3M™ Cavilon™ Advanced Skin Protectant (OTHER).
Who is sponsoring clinical trial NCT03546803?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03546803 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
RECRUITING · NA
-
M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis
RECRUITING · NA
-
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
COMPLETED · Phase 3
-
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
COMPLETED · NA
-
Bacterial Decolonization to Prevent Radiation Dermatitis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy